trimebutine has been researched along with rizatriptan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Bigal, ME; Filho, PF; Krymchantowski, AV | 1 |
| Olesen, J; Tfelt-Hansen, P | 1 |
1 trial(s) available for trimebutine and rizatriptan
| Article | Year |
|---|---|
Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Drug Combinations; Female; Gastrointestinal Agents; Gastroparesis; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Placebo Effect; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Trimebutine; Tryptamines | 2006 |
2 other study(ies) available for trimebutine and rizatriptan
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Increasing the effect of triptans in migraine.
Topics: Cross-Over Studies; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Trimebutine; Tryptamines | 2006 |